| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Masakazu Hatano, Hiroyuki Kamei, Ippei Takeuchi, Kazuhiko Gomi, Takashi Sakakibara, Shogo Hotta, Satoru Esumi, Kiyotaka Tsubouchi, Yoshihito Shimizu, Shigeki Yamad. Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study. BMC psychiatry. vol 23. issue 1. 2023-09-15. PMID:37715155. |
clozapine is the only antipsychotic medication with proven efficacy against treatment-resistant schizophrenia. |
2023-09-15 |
2023-10-07 |
Not clear |
| Yachana Panchal, Jessica M Gannon, Janina-Marie Tatar, G K Balasubraman. COVID-19 vaccination among patients with schizophrenia prescribed clozapine. Schizophrenia research. vol 261. 2023-09-10. PMID:37690168. |
covid-19 vaccination among patients with schizophrenia prescribed clozapine. |
2023-09-10 |
2023-10-07 |
Not clear |
| Masaru Tsukahara, Ryuhei So, Yusaku Yoshimura, Rieko Yamashita, Yuji Yada, Masafumi Kodama, Shinichiro Nakajima, Yoshiki Kishi, Toshihiko Takeda, Norihito Yamada, Hiroyoshi Takeuch. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study. Acta psychiatrica Scandinavica. 2023-09-08. PMID:37681448. |
effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: a 1-year retrospective cohort study. |
2023-09-08 |
2023-10-07 |
Not clear |
| Masaru Tsukahara, Ryuhei So, Yusaku Yoshimura, Rieko Yamashita, Yuji Yada, Masafumi Kodama, Shinichiro Nakajima, Yoshiki Kishi, Toshihiko Takeda, Norihito Yamada, Hiroyoshi Takeuch. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study. Acta psychiatrica Scandinavica. 2023-09-08. PMID:37681448. |
thus, we aimed to examine the effect of smoking habits and concomitant vpa use on relapse during the first year after discharge in patients with treatment-resistant schizophrenia (trs) receiving clozapine. |
2023-09-08 |
2023-10-07 |
Not clear |
| Phillipa Louise Brothwood, Mina Husain, Jessica Pinson, Ebenezer Oloyede, Patrick Davey, Eromona Whiske. Clozapine in Combination With Olanzapine Long-Acting Injection: The Intersection of Treatment-Resistant Schizophrenia and Poor Medication Adherence-A Case Report. Journal of clinical psychopharmacology. vol 43. issue 5. 2023-09-08. PMID:37683245. |
clozapine in combination with olanzapine long-acting injection: the intersection of treatment-resistant schizophrenia and poor medication adherence-a case report. |
2023-09-08 |
2023-10-07 |
Not clear |
| Soumitra Das, Annie Itrat, Mary Elizabeth Trejo Hernandez, Rasish Subedi, Thusanth Jogarajah, Sreshatha Vashist, Nikitha Daggal. Clozapine-induced eosinophilia: A case report. SAGE open medical case reports. vol 11. 2023-09-05. PMID:37667744. |
clozapine is one of the best atypical antipsychotics and is highly effective in treating treatment-resistant schizophrenia. |
2023-09-05 |
2023-09-07 |
Not clear |
| Soumitra Das, Annie Itrat, Mary Elizabeth Trejo Hernandez, Rasish Subedi, Thusanth Jogarajah, Sreshatha Vashist, Nikitha Daggal. Clozapine-induced eosinophilia: A case report. SAGE open medical case reports. vol 11. 2023-09-05. PMID:37667744. |
evidence suggests that clozapine appears to be effective in lowering the risk of suicide, extrapyramidal side effects, and relapse in patients with schizophrenia. |
2023-09-05 |
2023-09-07 |
Not clear |
| Soumitra Das, Annie Itrat, Mary Elizabeth Trejo Hernandez, Rasish Subedi, Thusanth Jogarajah, Sreshatha Vashist, Nikitha Daggal. Clozapine-induced eosinophilia: A case report. SAGE open medical case reports. vol 11. 2023-09-05. PMID:37667744. |
the current study aimed to report the incidence of eosinophilia associated with clozapine use in patients with schizophrenia. |
2023-09-05 |
2023-09-07 |
Not clear |
| Soumitra Das, Annie Itrat, Mary Elizabeth Trejo Hernandez, Rasish Subedi, Thusanth Jogarajah, Sreshatha Vashist, Nikitha Daggal. Clozapine-induced eosinophilia: A case report. SAGE open medical case reports. vol 11. 2023-09-05. PMID:37667744. |
a case study was done on a patient with schizophrenia and autistic spectrum disorder who was on clozapine. |
2023-09-05 |
2023-09-07 |
Not clear |
| Kenya Watanabe, Shingen Misaka, Keiko Kanno-Nozaki, Takaaki Chiyoda, Yuhei Suzuki, Akiko Sato, Takahiro Suto, Junko Kuroda, Kenju Shimomura, Itaru Miura, Hirooki Yab. Effect of lemborexant on pharmacokinetics of clozapine: A potential drug-drug interaction mediated by time-dependent inhibition of CYP3A4. British journal of clinical pharmacology. 2023-09-04. PMID:37596710. |
clozapine (clz) is extensively used for treatment-resistant schizophrenia (trs) with caution to avoid serious adverse events such as agranulocytosis and drug-drug interactions (ddis). |
2023-09-04 |
2023-09-07 |
Not clear |
| Gilbert Honigfel. Clozapine in treatment-resistant schizophrenia: Who designed that famous US clinical trial? Schizophrenia research. 2023-09-01. PMID:37657999. |
clozapine in treatment-resistant schizophrenia: who designed that famous us clinical trial? |
2023-09-01 |
2023-09-07 |
Not clear |
| Nuree Kang, Se Hyun Kim, Jayoun Kim, Sungkyu Kim, Jinhyeok Jang, Heesoo Yoon, Junhee Lee, Minah Kim, Yong Sik Kim, Jun Soo Kwo. Association between initial pattern of clozapine titration, concentration-to-dose ratio, and incidence of fever in patients with schizophrenia spectrum disorders in a Korean tertiary hospital. Schizophrenia research. 2023-08-26. PMID:37633775. |
in this retrospective study, 1408 korean schizophrenia inpatients were examined for during the first 8 weeks of clozapine titration. |
2023-08-26 |
2023-09-07 |
Not clear |
| Nuree Kang, Se Hyun Kim, Jayoun Kim, Sungkyu Kim, Jinhyeok Jang, Heesoo Yoon, Junhee Lee, Minah Kim, Yong Sik Kim, Jun Soo Kwo. Association between initial pattern of clozapine titration, concentration-to-dose ratio, and incidence of fever in patients with schizophrenia spectrum disorders in a Korean tertiary hospital. Schizophrenia research. 2023-08-26. PMID:37633775. |
in summary, the target dose of clozapine titration is lower for korean schizophrenia patients, with a higher c/d ratio and more frequent fever compared to western patients; however, myocarditis occurs rarely. |
2023-08-26 |
2023-09-07 |
Not clear |
| Claire Law, Yuen Mei See, Jie Yin Yee, Boon Tat Ng, Charmaine Tang, Jimmy Le. The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia. The Journal of clinical psychiatry. vol 84. issue 5. 2023-08-24. PMID:37616477. |
the impact of clozapine delay on clinical outcomes in schizophrenia. |
2023-08-24 |
2023-09-07 |
Not clear |
| Ta-Chun Lin, Ching-Hua Li. Schizophrenia patients discharged on clozapine plus long-acting injectable antipsychotics from a public psychiatric hospital in Taiwan, 2006-2021. The international journal of neuropsychopharmacology. 2023-08-24. PMID:37616565. |
schizophrenia patients discharged on clozapine plus long-acting injectable antipsychotics from a public psychiatric hospital in taiwan, 2006-2021. |
2023-08-24 |
2023-09-07 |
Not clear |
| Ta-Chun Lin, Ching-Hua Li. Schizophrenia patients discharged on clozapine plus long-acting injectable antipsychotics from a public psychiatric hospital in Taiwan, 2006-2021. The international journal of neuropsychopharmacology. 2023-08-24. PMID:37616565. |
some schizophrenia patients treated with clozapine experience an inadequate response and adherence problems. |
2023-08-24 |
2023-09-07 |
Not clear |
| Ta-Chun Lin, Ching-Hua Li. Schizophrenia patients discharged on clozapine plus long-acting injectable antipsychotics from a public psychiatric hospital in Taiwan, 2006-2021. The international journal of neuropsychopharmacology. 2023-08-24. PMID:37616565. |
the purpose of this study was to compare time to rehospitalization within 6 months in schizophrenia patients discharged on three clozapine regimens. |
2023-08-24 |
2023-09-07 |
Not clear |
| Robert D Maynard, Tony Funk, William Harrill, Jenny Jin, Dawn Smith, Gina Smith, Nichole Korpi-Steine. Analytical Performance Evaluation of Three Point-of-Care CBC Analyzers for Management of Clozapine Therapy in Ambulatory Psychiatry Clinics. The journal of applied laboratory medicine. 2023-08-23. PMID:37608429. |
clozapine is a first-line therapy and the only fda-approved drug for patients with treatment-resistant schizophrenia (trs). |
2023-08-23 |
2023-09-07 |
Not clear |
| Zijiao Ding, Huiting Jia, Ziqian Yang, Nan Yao, Yunyun Wan. The cardiovascular toxicity of clozapine in embryonic zebrafish and RNA sequencing-based transcriptome analysis. Journal of applied toxicology : JAT. 2023-08-22. PMID:37605992. |
clozapine (clz) is the most prescribed medication for treating refractory schizophrenia but is associated with significant cardiovascular toxicity. |
2023-08-22 |
2023-09-07 |
zebrafish |
| Mark Ainsley Colij. Response to Treatment in 3q29 Deletion Syndrome-Associated Psychosis: A Mini-Review. Neuropsychobiology. 2023-08-22. PMID:37607488. |
as such, clozapine therapy should be considered in such individuals, provided they meet criteria for treatment-resistant schizophrenia and no contraindications exist. |
2023-08-22 |
2023-09-07 |
Not clear |